| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.948 | 0.002 | 0.948 | Bruton tyrosine kinase inhibitor | 0.752 0.003 DBMET02020 0.155 0.007 DBMET02021 0.632 0.003 DBMET02022 0.948 0.002 DBMET02023 0.829 0.003 DBMET02025 0.849 0.002 DBMET02027 0.849 0.002 DBMET02024 0.829 0.003 DBMET02026 0.518 0.003 DBMET02028 | ||
| 0.898 | 0.004 | 0.898 | Tyrosine kinase inhibitor | 0.869 0.005 DBMET02020 0.611 0.01 DBMET02022 0.898 0.004 DBMET02023 0.758 0.005 DBMET02025 0.816 0.005 DBMET02027 0.816 0.005 DBMET02024 0.758 0.005 DBMET02026 0.539 0.015 DBMET02028 | ||
| 0.707 | 0.029 | 0.83 | Antiinflammatory | 0.559 0.065 DBMET02020 0.71 0.029 DBMET02022 0.707 0.029 DBMET02023 0.83 0.012 DBMET02025 0.819 0.013 DBMET02027 0.819 0.013 DBMET02024 0.83 0.012 DBMET02026 0.759 0.021 DBMET02028 | DBMET02026 | |
| 0.611 | 0.01 | 0.658 | Immunomodulator | 0.536 0.018 DBMET02020 0.647 0.008 DBMET02021 0.658 0.007 DBMET02022 0.611 0.01 DBMET02023 0.513 0.021 DBMET02025 0.525 0.02 DBMET02027 0.525 0.02 DBMET02024 0.513 0.021 DBMET02026 0.399 0.044 DBMET02028 | DBMET02022 | |
| 0.589 | 0.008 | 0.589 | Growth factor antagonist | 0.477 0.013 DBMET02020 0.247 0.035 DBMET02022 0.589 0.008 DBMET02023 0.223 0.04 DBMET02025 0.3 0.027 DBMET02027 0.3 0.027 DBMET02024 0.223 0.04 DBMET02026 0.113 0.099 DBMET02028 | ||
| 0.579 | 0.003 | 0.579 | Tyrosine-protein kinase EMT inhibitor | 0.383 0.004 DBMET02020 0.186 0.005 DBMET02022 0.579 0.003 DBMET02023 0.13 0.011 DBMET02025 0.15 0.009 DBMET02027 0.15 0.009 DBMET02024 0.13 0.011 DBMET02026 | ||
| 0.542 | 0.005 | 0.666 | EphB2 antagonist | 0.666 0.004 DBMET02020 0.266 0.049 DBMET02021 0.454 0.01 DBMET02022 0.542 0.005 DBMET02023 0.569 0.005 DBMET02025 0.544 0.005 DBMET02027 0.544 0.005 DBMET02024 0.569 0.005 DBMET02026 0.523 0.006 DBMET02028 | DBMET02020 | |
| 0.535 | 0.003 | 0.709 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.709 0.002 DBMET02020 0.21 0.005 DBMET02021 0.455 0.003 DBMET02022 0.535 0.003 DBMET02023 0.553 0.002 DBMET02025 0.562 0.002 DBMET02027 0.562 0.002 DBMET02024 0.553 0.002 DBMET02026 0.536 0.003 DBMET02028 | DBMET02020 | |
| 0.534 | 0.004 | 0.587 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.587 0.004 DBMET02020 0.21 0.039 DBMET02021 0.43 0.006 DBMET02022 0.534 0.004 DBMET02023 0.416 0.006 DBMET02025 0.447 0.005 DBMET02027 0.447 0.005 DBMET02024 0.416 0.006 DBMET02026 0.444 0.005 DBMET02028 | DBMET02020 | |
| 0.516 | 0.004 | 0.516 | Epidermal growth factor antagonist | 0.321 0.007 DBMET02020 0.075 0.072 DBMET02021 0.203 0.014 DBMET02022 0.516 0.004 DBMET02023 0.309 0.007 DBMET02025 0.348 0.006 DBMET02027 0.348 0.006 DBMET02024 0.309 0.007 DBMET02026 0.153 0.023 DBMET02028 | ||
| 0.477 | 0.005 | 0.543 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.543 0.004 DBMET02020 0.196 0.077 DBMET02021 0.412 0.011 DBMET02022 0.477 0.005 DBMET02023 0.452 0.006 DBMET02025 0.462 0.005 DBMET02027 0.462 0.005 DBMET02024 0.452 0.006 DBMET02026 0.423 0.01 DBMET02028 | DBMET02020 | |
| 0.466 | 0.004 | 0.466 | ErbB-4 antagonist | 0.299 0.005 DBMET02020 0.198 0.013 DBMET02022 0.466 0.004 DBMET02023 0.23 0.009 DBMET02025 0.259 0.007 DBMET02027 0.259 0.007 DBMET02024 0.23 0.009 DBMET02026 0.098 0.041 DBMET02028 | ||
| 0.433 | 0.005 | 0.433 | Epidermal growth factor receptor kinase inhibitor | 0.297 0.009 DBMET02020 0.223 0.02 DBMET02022 0.433 0.005 DBMET02023 0.291 0.01 DBMET02025 0.319 0.008 DBMET02027 0.319 0.008 DBMET02024 0.291 0.01 DBMET02026 0.173 0.036 DBMET02028 | ||
| 0.433 | 0.01 | 0.594 | Src kinase inhibitor | 0.594 0.005 DBMET02020 0.147 0.085 DBMET02021 0.295 0.026 DBMET02022 0.433 0.01 DBMET02023 0.384 0.014 DBMET02025 0.409 0.012 DBMET02027 0.409 0.012 DBMET02024 0.384 0.014 DBMET02026 0.333 0.02 DBMET02028 | DBMET02020 | |
| 0.424 | 0.006 | 0.601 | c-Src kinase inhibitor | 0.601 0.004 DBMET02020 0.16 0.05 DBMET02021 0.335 0.013 DBMET02022 0.424 0.006 DBMET02023 0.448 0.005 DBMET02025 0.474 0.005 DBMET02027 0.474 0.005 DBMET02024 0.448 0.005 DBMET02026 0.415 0.007 DBMET02028 | DBMET02020 | |
| 0.38 | 0.018 | 0.464 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.464 0.005 DBMET02020 0.236 0.068 DBMET02021 0.366 0.021 DBMET02022 0.38 0.018 DBMET02023 0.227 0.073 DBMET02025 0.289 0.043 DBMET02027 0.289 0.043 DBMET02024 0.227 0.073 DBMET02026 0.27 0.051 DBMET02028 | DBMET02020 | |
| 0.366 | 0.004 | 0.472 | Phosphatidylinositol 3-kinase delta inhibitor | 0.472 0.004 DBMET02020 0.051 0.046 DBMET02021 0.295 0.005 DBMET02022 0.366 0.004 DBMET02023 0.34 0.005 DBMET02025 0.374 0.004 DBMET02027 0.374 0.004 DBMET02024 0.34 0.005 DBMET02026 0.365 0.004 DBMET02028 | DBMET02020 | |
| 0.344 | 0.015 | 0.487 | RET inhibitor | 0.487 0.006 DBMET02020 0.231 0.035 DBMET02022 0.344 0.015 DBMET02023 0.362 0.013 DBMET02025 0.394 0.01 DBMET02027 0.394 0.01 DBMET02024 0.362 0.013 DBMET02026 0.374 0.012 DBMET02028 | DBMET02020 | |
| 0.338 | 0.018 | 0.535 | TRKC antagonist | 0.535 0.005 DBMET02020 0.314 0.023 DBMET02022 0.338 0.018 DBMET02023 0.186 0.075 DBMET02025 0.235 0.053 DBMET02027 0.235 0.053 DBMET02024 0.186 0.075 DBMET02026 0.204 0.065 DBMET02028 | DBMET02020 | |
| 0.328 | 0.015 | 0.395 | Protein-tyrosine kinase Lyn inhibitor | 0.395 0.007 DBMET02020 0.227 0.036 DBMET02022 0.328 0.015 DBMET02023 0.199 0.046 DBMET02025 0.223 0.038 DBMET02027 0.223 0.038 DBMET02024 0.199 0.046 DBMET02026 0.164 0.059 DBMET02028 | DBMET02020 | |
| 0.325 | 0.016 | 0.439 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.439 0.005 DBMET02020 0.225 0.105 DBMET02021 0.308 0.022 DBMET02022 0.325 0.016 DBMET02023 0.287 0.032 DBMET02025 0.293 0.028 DBMET02027 0.293 0.028 DBMET02024 0.287 0.032 DBMET02026 0.301 0.025 DBMET02028 | DBMET02020 | |
| 0.331 | 0.023 | 0.471 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.471 0.007 DBMET02020 0.281 0.037 DBMET02022 0.331 0.023 DBMET02023 0.198 0.067 DBMET02025 0.31 0.028 DBMET02027 0.31 0.028 DBMET02024 0.198 0.067 DBMET02026 0.173 0.079 DBMET02028 | DBMET02020 | |
| 0.31 | 0.004 | 0.31 | ErbB-3 antagonist | 0.261 0.005 DBMET02020 0.148 0.019 DBMET02021 0.217 0.007 DBMET02022 0.31 0.004 DBMET02023 0.256 0.005 DBMET02025 0.223 0.007 DBMET02027 0.223 0.007 DBMET02024 0.256 0.005 DBMET02026 0.12 0.029 DBMET02028 | ||
| 0.304 | 0.016 | 0.408 | Lck kinase inhibitor | 0.408 0.008 DBMET02020 0.207 0.038 DBMET02022 0.304 0.016 DBMET02023 0.152 0.064 DBMET02025 0.167 0.056 DBMET02027 0.167 0.056 DBMET02024 0.152 0.064 DBMET02026 0.123 0.083 DBMET02028 | DBMET02020 | |
| 0.29 | 0.012 | 0.528 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.528 0.005 DBMET02020 0.249 0.017 DBMET02022 0.29 0.012 DBMET02023 0.316 0.01 DBMET02025 0.361 0.008 DBMET02027 0.361 0.008 DBMET02024 0.316 0.01 DBMET02026 0.349 0.008 DBMET02028 | DBMET02020 | |
| 0.29 | 0.012 | 0.527 | Abl kinase inhibitor | 0.527 0.005 DBMET02020 0.248 0.017 DBMET02022 0.29 0.012 DBMET02023 0.316 0.01 DBMET02025 0.361 0.008 DBMET02027 0.361 0.008 DBMET02024 0.316 0.01 DBMET02026 0.349 0.008 DBMET02028 | DBMET02020 | |
| 0.281 | 0.011 | 0.39 | Ephrin antagonist | 0.39 0.005 DBMET02020 0.24 0.016 DBMET02022 0.281 0.011 DBMET02023 0.28 0.011 DBMET02025 0.291 0.01 DBMET02027 0.291 0.01 DBMET02024 0.28 0.011 DBMET02026 0.247 0.015 DBMET02028 | DBMET02020 | |
| 0.336 | 0.076 | 0.353 | Angiogenesis inhibitor | 0.257 0.117 DBMET02020 0.336 0.076 DBMET02023 0.343 0.074 DBMET02025 0.353 0.07 DBMET02027 0.353 0.07 DBMET02024 0.343 0.074 DBMET02026 | DBMET02024 | |
| 0.26 | 0.007 | 0.26 | Janus tyrosine kinase 3 inhibitor | 0.161 0.017 DBMET02020 0.075 0.048 DBMET02022 0.26 0.007 DBMET02023 0.073 0.05 DBMET02027 0.073 0.05 DBMET02024 | ||
| 0.254 | 0.004 | 0.254 | Fibroblast growth factor 2 antagonist | 0.154 0.01 DBMET02020 0.119 0.018 DBMET02022 0.254 0.004 DBMET02023 0.088 0.029 DBMET02027 0.088 0.029 DBMET02024 | ||
| 0.212 | 0.004 | 0.317 | DNA-dependent protein kinase inhibitor | 0.317 0.003 DBMET02020 0.05 0.021 DBMET02021 0.177 0.004 DBMET02022 0.212 0.004 DBMET02023 0.25 0.004 DBMET02025 0.264 0.004 DBMET02027 0.264 0.004 DBMET02024 0.25 0.004 DBMET02026 0.274 0.004 DBMET02028 | DBMET02020 | |
| 0.197 | 0.001 | 0.197 | MAP kinase kinase 7 inhibitor | 0.169 0.002 DBMET02020 0.145 0.003 DBMET02022 0.197 0.001 DBMET02023 0.083 0.038 DBMET02025 0.102 0.012 DBMET02027 0.102 0.012 DBMET02024 0.083 0.038 DBMET02026 0.073 0.07 DBMET02028 | ||
| 0.2 | 0.008 | 0.348 | Phosphatidylinositol kinase inhibitor | 0.348 0.005 DBMET02020 0.182 0.009 DBMET02022 0.2 0.008 DBMET02023 0.079 0.029 DBMET02025 0.102 0.02 DBMET02027 0.102 0.02 DBMET02024 0.079 0.029 DBMET02026 0.101 0.021 DBMET02028 | DBMET02020 | |
| 0.235 | 0.046 | 0.292 | I kappa B kinase epsilon inhibitor | 0.292 0.018 DBMET02020 0.146 0.124 DBMET02022 0.235 0.046 DBMET02023 | DBMET02020 | |
| 0.203 | 0.015 | 0.384 | TIE antagonist | 0.384 0.005 DBMET02020 0.103 0.039 DBMET02022 0.203 0.015 DBMET02023 0.139 0.025 DBMET02025 0.151 0.023 DBMET02027 0.151 0.023 DBMET02024 0.139 0.025 DBMET02026 0.103 0.039 DBMET02028 | DBMET02020 | |
| 0.201 | 0.014 | 0.38 | TIE-2 antagonist | 0.38 0.005 DBMET02020 0.103 0.038 DBMET02022 0.201 0.014 DBMET02023 0.139 0.024 DBMET02025 0.152 0.022 DBMET02027 0.152 0.022 DBMET02024 0.139 0.024 DBMET02026 0.103 0.038 DBMET02028 | DBMET02020 | |
| 0.181 | 0.005 | 0.23 | mTOR complex 2 inhibitor | 0.23 0.004 DBMET02020 0.205 0.004 DBMET02022 0.181 0.005 DBMET02023 0.087 0.052 DBMET02025 0.116 0.02 DBMET02027 0.116 0.02 DBMET02024 0.087 0.052 DBMET02026 0.131 0.013 DBMET02028 | DBMET02020 | |
| 0.258 | 0.093 | 0.464 | Immunostimulant | 0.464 0.034 DBMET02021 0.265 0.09 DBMET02022 0.258 0.093 DBMET02023 0.234 0.103 DBMET02025 0.197 0.122 DBMET02027 0.197 0.122 DBMET02024 0.234 0.103 DBMET02026 | DBMET02021 | |
| 0.175 | 0.013 | 0.175 | ErbB-2 antagonist | 0.165 0.015 DBMET02020 0.125 0.026 DBMET02022 0.175 0.013 DBMET02023 0.072 0.057 DBMET02025 0.087 0.042 DBMET02027 0.087 0.042 DBMET02024 0.072 0.057 DBMET02026 | ||
| 0.297 | 0.138 | 0.379 | MAP kinase kinase 6 inhibitor | 0.379 0.072 DBMET02020 0.255 0.184 DBMET02022 0.297 0.138 DBMET02023 | DBMET02020 | |
| 0.155 | 0.01 | 0.261 | EphB4 antagonist | 0.261 0.005 DBMET02020 0.091 0.02 DBMET02022 0.155 0.01 DBMET02023 0.058 0.041 DBMET02027 0.058 0.041 DBMET02024 | DBMET02020 | |
| 0.153 | 0.01 | 0.203 | mTOR complex 1 inhibitor | 0.142 0.014 DBMET02020 0.121 0.027 DBMET02022 0.153 0.01 DBMET02023 0.171 0.008 DBMET02025 0.203 0.006 DBMET02027 0.203 0.006 DBMET02024 0.171 0.008 DBMET02026 0.151 0.011 DBMET02028 | DBMET02024 | |
| 0.166 | 0.026 | 0.166 | Fibroblast growth factor 1 antagonist | 0.104 0.054 DBMET02020 0.166 0.026 DBMET02023 0.081 0.074 DBMET02027 0.081 0.074 DBMET02024 | ||
| 0.174 | 0.039 | 0.412 | Protein kinase (CK1) delta inhibitor | 0.412 0.006 DBMET02020 0.159 0.048 DBMET02022 0.174 0.039 DBMET02023 0.135 0.062 DBMET02025 0.177 0.038 DBMET02027 0.177 0.038 DBMET02024 0.135 0.062 DBMET02026 0.175 0.039 DBMET02028 | DBMET02020 | |
| 0.14 | 0.011 | 0.232 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.232 0.006 DBMET02020 0.143 0.011 DBMET02022 0.14 0.011 DBMET02023 0.045 0.042 DBMET02025 0.063 0.028 DBMET02027 0.063 0.028 DBMET02024 0.045 0.042 DBMET02026 0.065 0.027 DBMET02028 | DBMET02020 | |
| 0.151 | 0.029 | 0.202 | EphA2 antagonist | 0.202 0.013 DBMET02020 0.134 0.041 DBMET02022 0.151 0.029 DBMET02023 0.132 0.043 DBMET02025 0.133 0.042 DBMET02027 0.133 0.042 DBMET02024 0.132 0.043 DBMET02026 0.118 0.057 DBMET02028 | DBMET02020 | |
| 0.161 | 0.04 | 0.337 | TRKB antagonist | 0.337 0.008 DBMET02020 0.162 0.04 DBMET02022 0.161 0.04 DBMET02023 | DBMET02020 | |
| 0.164 | 0.044 | 0.289 | MAP kinase kinase inhibitor | 0.214 0.024 DBMET02020 0.289 0.01 DBMET02022 0.164 0.044 DBMET02023 0.106 0.089 DBMET02027 0.106 0.089 DBMET02024 | DBMET02022 | |
| 0.143 | 0.032 | 0.253 | Activin receptor-like kinase 4 inhibitor | 0.253 0.007 DBMET02020 0.133 0.039 DBMET02022 0.143 0.032 DBMET02023 0.137 0.036 DBMET02025 0.152 0.027 DBMET02027 0.152 0.027 DBMET02024 0.137 0.036 DBMET02026 0.153 0.027 DBMET02028 | DBMET02020 | |
| 0.16 | 0.059 | 0.451 | Tyrosine-protein kinase receptor antagonist | 0.451 0.006 DBMET02020 0.241 0.028 DBMET02022 0.16 0.059 DBMET02023 | DBMET02020 | |
| 0.116 | 0.022 | 0.116 | Phosphodiesterase XI inhibitor | 0.085 0.049 DBMET02020 0.089 0.044 DBMET02022 0.116 0.022 DBMET02023 | ||
| 0.116 | 0.022 | 0.116 | Phosphodiesterase 11A inhibitor | 0.085 0.049 DBMET02020 0.089 0.044 DBMET02022 0.116 0.022 DBMET02023 | ||
| 0.157 | 0.062 | 0.385 | Protein kinase (CK1) inhibitor | 0.385 0.009 DBMET02020 0.155 0.063 DBMET02022 0.157 0.062 DBMET02023 0.105 0.104 DBMET02025 0.147 0.07 DBMET02027 0.147 0.07 DBMET02024 0.105 0.104 DBMET02026 0.141 0.075 DBMET02028 | DBMET02020 | |
| 0.107 | 0.014 | 0.217 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.217 0.006 DBMET02020 0.085 0.018 DBMET02022 0.107 0.014 DBMET02023 0.097 0.015 DBMET02025 0.115 0.013 DBMET02027 0.115 0.013 DBMET02024 0.097 0.015 DBMET02026 0.122 0.012 DBMET02028 | DBMET02020 | |
| 0.192 | 0.099 | 0.255 | ErbB-1 antagonist | 0.178 0.119 DBMET02020 0.192 0.099 DBMET02023 0.235 0.06 DBMET02025 0.255 0.049 DBMET02027 0.255 0.049 DBMET02024 0.235 0.06 DBMET02026 | DBMET02024 | |
| 0.099 | 0.009 | 0.099 | Fibroblast growth factor 4 antagonist | 0.099 0.009 DBMET02023 0.074 0.023 DBMET02025 0.087 0.014 DBMET02027 0.087 0.014 DBMET02024 0.074 0.023 DBMET02026 | ||
| 0.153 | 0.064 | 0.331 | Vascular endothelial growth factor 3 antagonist | 0.331 0.015 DBMET02020 0.153 0.064 DBMET02023 0.137 0.078 DBMET02027 0.137 0.078 DBMET02024 | DBMET02020 | |
| 0.092 | 0.014 | 0.205 | mTOR inhibitor | 0.205 0.004 DBMET02020 0.157 0.005 DBMET02022 0.092 0.014 DBMET02023 | DBMET02020 | |
| 0.088 | 0.015 | 0.171 | Phosphatidylinositol 3-kinase beta inhibitor | 0.171 0.006 DBMET02020 0.075 0.018 DBMET02022 0.088 0.015 DBMET02023 0.106 0.011 DBMET02025 0.128 0.009 DBMET02027 0.128 0.009 DBMET02024 0.106 0.011 DBMET02026 0.134 0.008 DBMET02028 | DBMET02020 | |
| 0.096 | 0.025 | 0.096 | MAP3K7 inhibitor | 0.096 0.025 DBMET02023 0.068 0.057 DBMET02025 0.073 0.05 DBMET02027 0.073 0.05 DBMET02024 0.068 0.057 DBMET02026 | ||
| 0.14 | 0.075 | 0.305 | Activin receptor-like kinase 2 inhibitor | 0.305 0.012 DBMET02020 0.14 0.075 DBMET02023 | DBMET02020 | |
| 0.121 | 0.056 | 0.202 | Polo-like kinase-4 inhibitor | 0.202 0.015 DBMET02020 0.109 0.067 DBMET02022 0.121 0.056 DBMET02023 | DBMET02020 | |
| 0.079 | 0.017 | 0.141 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.141 0.005 DBMET02020 0.07 0.02 DBMET02022 0.079 0.017 DBMET02023 | DBMET02020 | |
| 0.101 | 0.039 | 0.225 | AXL receptor tyrosine kinase inhibitor | 0.225 0.006 DBMET02020 0.105 0.035 DBMET02022 0.101 0.039 DBMET02023 | DBMET02020 | |
| 0.134 | 0.077 | 0.303 | Ribosomal protein S6 kinase inhibitor | 0.303 0.011 DBMET02020 0.141 0.071 DBMET02022 0.134 0.077 DBMET02023 0.112 0.1 DBMET02025 0.145 0.068 DBMET02027 0.145 0.068 DBMET02024 0.112 0.1 DBMET02026 0.152 0.063 DBMET02028 | DBMET02020 | |
| 0.091 | 0.035 | 0.147 | Protein kinase B alpha inhibitor | 0.147 0.01 DBMET02020 0.073 0.045 DBMET02022 0.091 0.035 DBMET02023 | DBMET02020 | |
| 0.226 | 0.171 | 0.454 | Toll-Like receptor 7 agonist | 0.27 0.13 DBMET02020 0.454 0.042 DBMET02022 0.226 0.171 DBMET02023 | DBMET02022 | |
| 0.092 | 0.038 | 0.099 | Fibroblast growth factor 3 antagonist | 0.099 0.033 DBMET02020 0.092 0.038 DBMET02023 | DBMET02020 | |
| 0.082 | 0.028 | 0.082 | Janus tyrosine kinase 1 inhibitor | 0.07 0.033 DBMET02020 0.082 0.028 DBMET02023 | ||
| 0.172 | 0.119 | 0.291 | Potassium channel (Voltage-sensitive) blocker | 0.291 0.052 DBMET02020 0.172 0.119 DBMET02023 | DBMET02020 | |
| 0.11 | 0.062 | 0.117 | Interleukin 2 antagonist | 0.117 0.049 DBMET02020 0.11 0.062 DBMET02023 | DBMET02020 | |
| 0.089 | 0.042 | 0.105 | Janus tyrosine kinase 2 inhibitor | 0.105 0.034 DBMET02020 0.089 0.042 DBMET02023 | DBMET02020 | |
| 0.096 | 0.049 | 0.195 | Insulin growth factor antagonist | 0.194 0.012 DBMET02020 0.195 0.012 DBMET02022 0.096 0.049 DBMET02023 | DBMET02022 | |
| 0.124 | 0.078 | 0.235 | Toll-Like receptor antagonist | 0.235 0.019 DBMET02020 0.124 0.078 DBMET02023 | DBMET02020 | |
| 0.091 | 0.048 | 0.186 | Insulin like growth factor 1 antagonist | 0.186 0.012 DBMET02020 0.185 0.012 DBMET02022 0.091 0.048 DBMET02023 | DBMET02020 | |
| 0.221 | 0.178 | 0.453 | Toll-Like receptor agonist | 0.266 0.134 DBMET02020 0.453 0.042 DBMET02022 0.221 0.178 DBMET02023 | DBMET02022 | |
| 0.114 | 0.072 | 0.255 | Vascular endothelial growth factor antagonist | 0.255 0.028 DBMET02020 0.114 0.072 DBMET02023 0.108 0.076 DBMET02025 0.151 0.054 DBMET02027 0.151 0.054 DBMET02024 0.108 0.076 DBMET02026 0.104 0.079 DBMET02028 | DBMET02020 | |
| 0.105 | 0.068 | 0.246 | Vascular endothelial growth factor 2 antagonist | 0.246 0.027 DBMET02020 0.105 0.068 DBMET02023 0.098 0.073 DBMET02025 0.14 0.052 DBMET02027 0.14 0.052 DBMET02024 0.098 0.073 DBMET02026 0.093 0.077 DBMET02028 | DBMET02020 | |
| 0.078 | 0.048 | 0.135 | Protein kinase B gamma inhibitor | 0.135 0.02 DBMET02020 0.078 0.048 DBMET02023 0.095 0.035 DBMET02025 0.127 0.023 DBMET02027 0.127 0.023 DBMET02024 0.095 0.035 DBMET02026 0.092 0.037 DBMET02028 | DBMET02020 | |
| 0.139 | 0.11 | 0.338 | LIM domain kinase 1 inhibitor | 0.338 0.014 DBMET02020 0.127 0.126 DBMET02022 0.139 0.11 DBMET02023 | DBMET02020 | |
| 0.098 | 0.074 | 0.138 | Granulocyte macrophage colony stimulating factor antagonist | 0.138 0.042 DBMET02020 0.116 0.056 DBMET02022 0.098 0.074 DBMET02023 | DBMET02020 | |
| 0.031 | 0.009 | 0.038 | Phosphodiesterase 9A inhibitor | 0.038 0.005 DBMET02020 0.028 0.011 DBMET02022 0.031 0.009 DBMET02023 | DBMET02020 | |
| 0.03 | 0.009 | 0.038 | Phosphodiesterase IX inhibitor | 0.038 0.005 DBMET02020 0.026 0.012 DBMET02022 0.03 0.009 DBMET02023 | DBMET02020 | |
| 0.129 | 0.112 | 0.235 | Polo-like kinase-3 inhibitor | 0.235 0.029 DBMET02020 0.151 0.083 DBMET02022 0.129 0.112 DBMET02023 | DBMET02020 | |
| 0.132 | 0.116 | 0.298 | CDC-like kinase 4 inhibitor | 0.298 0.032 DBMET02020 0.132 0.116 DBMET02023 | DBMET02020 | |
| 0.084 | 0.068 | 0.255 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.255 0.012 DBMET02020 0.084 0.068 DBMET02023 | DBMET02020 | |
| 0.036 | 0.035 | 0.036 | Integrin alpha1beta1 antagonist | 0.036 0.035 DBMET02023 | ||
| 0.14 | 0.139 | 0.266 | Death-associated protein kinase 3 inhibitor | 0.266 0.047 DBMET02020 0.14 0.139 DBMET02023 | DBMET02020 | |
| 0.077 | 0.077 | 0.092 | Transforming growth factor beta 3 antagonist | 0.092 0.034 DBMET02020 | DBMET02020 | |
| 0.065 | 0.067 | 0.094 | Protein kinase B beta inhibitor | 0.094 0.03 DBMET02020 | DBMET02020 | |
| 0.012 | 0.015 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.013 DBMET02020 0.014 0.012 DBMET02022 | DBMET02022 | |
| 0.065 | 0.068 | 0.079 | Phosphodiesterase VIII inhibitor | 0.079 0.036 DBMET02020 0.067 0.062 DBMET02022 | DBMET02020 | |
| 0.072 | 0.075 | 0.108 | Bcr-Abl kinase inhibitor | 0.108 0.034 DBMET02020 | DBMET02020 | |
| 0.078 | 0.086 | 0.162 | Aurora-A kinase inhibitor | 0.162 0.035 DBMET02020 | DBMET02020 | |
| 0.103 | 0.117 | 0.284 | Protein kinase C nu inhibitor | 0.284 0.028 DBMET02020 0.131 0.082 DBMET02027 0.131 0.082 DBMET02024 0.121 0.092 DBMET02028 | DBMET02020 | |
| 0.179 | 0.194 | 0.2 | MAP kinase kinase 3 inhibitor | 0.2 0.121 DBMET02020 | DBMET02020 | |
| 0.114 | 0.129 | 0.2 | Cyclin-dependent kinase 8 inhibitor | 0.2 0.035 DBMET02020 0.134 0.097 DBMET02022 | DBMET02020 | |
| 0.085 | 0.103 | 0.297 | Aurora-B kinase inhibitor | 0.297 0.016 DBMET02020 | DBMET02020 | |
| 0.087 | 0.109 | 0.249 | TRKA antagonist | 0.249 0.019 DBMET02020 0.126 0.063 DBMET02022 | DBMET02020 | |
| 0.125 | 0.148 | 0.355 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.355 0.027 DBMET02020 0.136 0.128 DBMET02022 | DBMET02020 | |
| 0.092 | 0.117 | 0.285 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.285 0.022 DBMET02020 | DBMET02020 | |
| 0.039 | 0.065 | 0.049 | Factor IXa inhibitor | 0.049 0.039 DBMET02020 0.047 0.042 DBMET02022 | DBMET02020 | |
| 0.04 | 0.068 | 0.059 | Tyk2 inhibitor | 0.059 0.05 DBMET02020 | DBMET02020 | |
| 0.127 | 0.156 | 0.242 | HERG channel blocker | 0.242 0.07 DBMET02020 | DBMET02020 | |
| 0.025 | 0.055 | 0.07 | ATR kinase inhibitor | 0.07 0.005 DBMET02020 | DBMET02020 | |
| 0.119 | 0.151 | 0.297 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.297 0.028 DBMET02020 0.154 0.116 DBMET02022 0.182 0.091 DBMET02027 0.182 0.091 DBMET02024 0.197 0.079 DBMET02028 | DBMET02020 | |
| 0.049 | 0.083 | 0.166 | Raf kinase inhibitor | 0.166 0.016 DBMET02020 | DBMET02020 | |
| 0.01 | 0.046 | 0.032 | Adenosine kinase inhibitor | 0.032 0.009 DBMET02020 | DBMET02020 | |
| 0.007 | 0.044 | 0.017 | Glucose-dependent insulinotropic receptor antagonist | 0.017 0.004 DBMET02021 | DBMET02021 | |
| 0.065 | 0.104 | 0.195 | Check point kinase 2 inhibitor | 0.195 0.018 DBMET02020 | DBMET02020 | |
| 0.028 | 0.07 | 0.109 | Protein kinase (CK1) epsilon inhibitor | 0.109 0.004 DBMET02020 | DBMET02020 | |
| 0.07 | 0.113 | 0.131 | Phosphodiesterase 7B inhibitor | 0.131 0.03 DBMET02020 | DBMET02020 | |
| 0.185 | 0.228 | 0.243 | GABA C receptor rho-3 antagonist | 0.243 0.16 DBMET02025 0.217 0.187 DBMET02027 0.217 0.187 DBMET02024 0.243 0.16 DBMET02026 | DBMET02026 | |
| 0.142 | 0.186 | 0.182 | MAP kinase kinase 5 inhibitor | 0.177 0.068 DBMET02020 0.182 0.058 DBMET02022 0.16 0.114 DBMET02027 0.16 0.114 DBMET02024 0.164 0.102 DBMET02028 | DBMET02022 | |
| 0.113 | 0.158 | 0.147 | MAP kinase 3 inhibitor | 0.147 0.073 DBMET02027 0.147 0.073 DBMET02024 | DBMET02024 | |
| 0.064 | 0.113 | 0.216 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.216 0.033 DBMET02020 | DBMET02020 | |
| 0.076 | 0.125 | 0.154 | MAP kinase 13 inhibitor | 0.154 0.034 DBMET02020 | DBMET02020 | |
| 0.032 | 0.084 | 0.142 | Raf kinase B inhibitor | 0.142 0.015 DBMET02020 | DBMET02020 | |
| 0.091 | 0.144 | 0.177 | Protein kinase (CK1) gamma 1 inhibitor | 0.177 0.051 DBMET02020 | DBMET02020 | |
| 0.06 | 0.115 | 0.148 | Vascular endothelial growth factor 1 antagonist | 0.148 0.042 DBMET02020 | DBMET02020 | |
| 0.106 | 0.162 | 0.26 | Clk dual-specificity kinase inhibitor | 0.26 0.051 DBMET02020 | DBMET02020 | |
| 0.09 | 0.148 | 0.259 | CDC-like kinase 2 inhibitor | 0.259 0.043 DBMET02020 | DBMET02020 | |
| 0.036 | 0.095 | 0.055 | Cyclin A1 inhibitor | 0.055 0.049 DBMET02020 | DBMET02020 | |
| 0.085 | 0.145 | 0.209 | Protein kinase (CK1) gamma inhibitor | 0.209 0.041 DBMET02020 | DBMET02020 | |
| 0.102 | 0.162 | 0.219 | Hemostatic | 0.17 0.048 DBMET02020 0.219 0.027 DBMET02022 0.183 0.04 DBMET02025 0.152 0.065 DBMET02027 0.152 0.065 DBMET02024 0.183 0.04 DBMET02026 | DBMET02022 | |
| 0.073 | 0.136 | 0.192 | Protein kinase (CK1) gamma 2 inhibitor | 0.192 0.034 DBMET02020 | DBMET02020 | |
| 0.074 | 0.138 | 0.156 | MAP kinase 12 inhibitor | 0.156 0.038 DBMET02020 | DBMET02020 | |
| 0.106 | 0.174 | 0.144 | Death-associated protein kinase 1 inhibitor | 0.144 0.049 DBMET02020 | DBMET02020 | |
| 0.138 | 0.208 | 0.247 | MAP-kinase-activated kinase 5 inhibitor | 0.247 0.061 DBMET02020 | DBMET02020 | |
| 0.025 | 0.095 | 0.058 | Adenosine A1 receptor antagonist | 0.058 0.041 DBMET02020 | DBMET02020 | |
| 0.054 | 0.126 | 0.171 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.171 0.015 DBMET02020 0.088 0.06 DBMET02022 | DBMET02020 | |
| 0.11 | 0.184 | 0.178 | Potassium channel blocker | 0.178 0.108 DBMET02020 | DBMET02020 | |
| 0.028 | 0.102 | 0.132 | Toll-Like receptor 8 antagonist | 0.132 0.005 DBMET02020 | DBMET02020 | |
| 0.056 | 0.132 | 0.129 | Hepatocyte growth factor antagonist | 0.129 0.03 DBMET02020 | DBMET02020 | |
| 0.103 | 0.183 | 0.353 | MAP kinase kinase 2 inhibitor | 0.353 0.02 DBMET02020 0.267 0.047 DBMET02022 0.206 0.078 DBMET02027 0.206 0.078 DBMET02024 0.159 0.113 DBMET02028 | DBMET02020 | |
| 0.151 | 0.235 | 0.28 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.28 0.079 DBMET02020 | DBMET02020 | |
| 0.044 | 0.129 | 0.119 | Platelet activating factor beta antagonist | 0.119 0.05 DBMET02020 | DBMET02020 | |
| 0.026 | 0.114 | 0.056 | Adenosine A2a receptor antagonist | 0.056 0.048 DBMET02020 | DBMET02020 | |
| 0.064 | 0.153 | 0.145 | MAP kinase kinase 1 inhibitor | 0.087 0.074 DBMET02020 0.145 0.019 DBMET02022 | DBMET02022 | |
| 0.026 | 0.124 | 0.057 | Purinergic P2X2 antagonist | 0.057 0.054 DBMET02020 | DBMET02020 | |
| 0.022 | 0.121 | 0.056 | CDK4/cyclin D1 inhibitor | 0.056 0.042 DBMET02020 | DBMET02020 | |
| 0.026 | 0.132 | 0.059 | Adenosine A2 receptor antagonist | 0.059 0.049 DBMET02020 | DBMET02020 | |
| 0.062 | 0.168 | 0.125 | Protein kinase C gamma inhibitor | 0.125 0.049 DBMET02020 | DBMET02020 | |
| 0.039 | 0.149 | 0.104 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.104 0.054 DBMET02020 | DBMET02020 | |
| 0.068 | 0.179 | 0.218 | Thrombolytic | 0.218 0.044 DBMET02021 0.19 0.057 DBMET02025 0.143 0.088 DBMET02027 0.143 0.088 DBMET02024 0.19 0.057 DBMET02026 0.158 0.075 DBMET02028 | DBMET02021 | |
| 0.105 | 0.219 | 0.224 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.224 0.062 DBMET02020 | DBMET02020 | |
| 0.023 | 0.144 | 0.061 | GABA A receptor antagonist | 0.061 0.03 DBMET02020 | DBMET02020 | |
| 0.038 | 0.16 | 0.123 | Cyclin-dependent kinase 1 inhibitor | 0.123 0.053 DBMET02020 | DBMET02020 | |
| 0.048 | 0.173 | 0.143 | Protein kinase C mu inhibitor | 0.143 0.029 DBMET02020 | DBMET02020 | |
| 0.063 | 0.189 | 0.151 | Phosphodiesterase inhibitor | 0.134 0.07 DBMET02020 0.151 0.057 DBMET02022 | DBMET02022 | |
| 0.086 | 0.213 | 0.184 | Growth hormone agonist | 0.165 0.076 DBMET02021 0.184 0.066 DBMET02025 0.184 0.066 DBMET02026 | DBMET02026 | |
| 0.007 | 0.135 | 0.087 | Leukotriene A4 hydrolase inhibitor | 0.087 0.007 DBMET02021 | DBMET02021 | |
| 0.031 | 0.165 | 0.1 | Leucine-rich repeat kinase 2 inhibitor | 0.1 0.043 DBMET02020 | DBMET02020 | |
| 0.026 | 0.163 | 0.077 | Toll-Like receptor 7 antagonist | 0.077 0.04 DBMET02020 | DBMET02020 | |
| 0.021 | 0.16 | 0.065 | GABA receptor antagonist | 0.065 0.028 DBMET02020 | DBMET02020 | |
| 0.031 | 0.171 | 0.064 | Phosphodiesterase 1B inhibitor | 0.064 0.037 DBMET02020 | DBMET02020 | |
| 0.099 | 0.248 | 0.144 | MAP kinase kinase 4 inhibitor | 0.144 0.075 DBMET02020 0.136 0.097 DBMET02022 | DBMET02020 | |
| 0.018 | 0.167 | 0.04 | Somatostatin 4 agonist | 0.04 0.022 DBMET02020 | DBMET02020 | |
| 0.046 | 0.201 | 0.117 | Insulin receptor antagonist | 0.117 0.044 DBMET02020 | DBMET02020 | |
| 0.058 | 0.214 | 0.194 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.194 0.067 DBMET02020 | DBMET02020 | |
| 0.035 | 0.196 | 0.072 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.072 0.056 DBMET02020 | DBMET02020 | |
| 0.072 | 0.236 | 0.155 | Protein kinase (CK1) gamma 3 inhibitor | 0.155 0.085 DBMET02020 | DBMET02020 | |
| 0.054 | 0.222 | 0.105 | Nav1.4 sodium channel blocker | 0.105 0.069 DBMET02021 | DBMET02021 | |
| 0.069 | 0.248 | 0.174 | MAP3K9 inhibitor | 0.135 0.086 DBMET02022 0.174 0.032 DBMET02027 0.174 0.032 DBMET02024 0.168 0.037 DBMET02028 | DBMET02024 | |
| 0.046 | 0.226 | 0.102 | Cyclin-dependent kinase inhibitor | 0.102 0.088 DBMET02020 | DBMET02020 | |
| 0.039 | 0.219 | 0.086 | MAP kinase 9 inhibitor | 0.086 0.076 DBMET02020 | DBMET02020 | |
| 0.044 | 0.226 | 0.097 | Phosphodiesterase I inhibitor | 0.097 0.048 DBMET02020 | DBMET02020 | |
| 0.03 | 0.214 | 0.094 | Protein kinase A inhibitor | 0.094 0.049 DBMET02020 | DBMET02020 | |
| 0.014 | 0.212 | 0.05 | Adenosine deaminase inhibitor | 0.05 0.03 DBMET02027 0.05 0.03 DBMET02024 | DBMET02024 | |
| 0.043 | 0.245 | 0.151 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.151 0.076 DBMET02020 | DBMET02020 | |
| 0.042 | 0.247 | 0.084 | Factor XII inhibitor | 0.084 0.058 DBMET02021 | DBMET02021 | |
| 0.021 | 0.227 | 0.049 | Histamine H4 receptor antagonist | 0.049 0.032 DBMET02020 | DBMET02020 | |
| 0.067 | 0.274 | 0.134 | Hexokinase inhibitor | 0.121 0.117 DBMET02020 0.134 0.099 DBMET02022 | DBMET02022 | |
| 0.063 | 0.275 | 0.12 | Heat shock protein 90 antagonist | 0.12 0.114 DBMET02020 | DBMET02020 | |
| 0.053 | 0.285 | 0.113 | Adenylate kinase inhibitor | 0.113 0.05 DBMET02025 0.113 0.05 DBMET02026 | DBMET02026 | |
| 0.017 | 0.278 | 0.082 | Rho-associated kinase I inhibitor | 0.082 0.045 DBMET02020 | DBMET02020 | |
| 0.016 | 0.282 | 0.083 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.083 0.048 DBMET02020 | DBMET02020 | |
| 0.061 | 0.33 | 0.173 | DNA methylase inhibitor | 0.173 0.098 DBMET02025 0.173 0.098 DBMET02026 | DBMET02026 | |
| 0.056 | 0.333 | 0.154 | DNA methyltransferase I inhibitor | 0.154 0.1 DBMET02025 0.154 0.1 DBMET02026 | DBMET02026 | |
| 0.008 | 0.285 | 0.046 | Phosphodiesterase 2A inhibitor | 0.046 0.041 DBMET02027 0.046 0.041 DBMET02024 0.046 0.041 DBMET02028 | DBMET02028 | |
| 0.018 | 0.302 | 0.052 | Guanylate cyclase stimulant | 0.052 0.019 DBMET02025 0.045 0.027 DBMET02027 0.045 0.027 DBMET02024 0.052 0.019 DBMET02026 0.04 0.039 DBMET02028 | DBMET02026 | |
| 0.026 | 0.311 | 0.089 | MAP-kinase-activated kinase inhibitor | 0.089 0.05 DBMET02020 | DBMET02020 | |
| 0.058 | 0.345 | 0.191 | Platelet aggregation inhibitor | 0.191 0.088 DBMET02025 0.191 0.088 DBMET02026 | DBMET02026 | |
| 0.032 | 0.319 | 0.082 | Aminoacyl-tRNA synthetase inhibitor | 0.082 0.074 DBMET02021 | DBMET02021 | |
| 0.007 | 0.296 | 0.054 | Phosphodiesterase II inhibitor | 0.054 0.041 DBMET02027 0.054 0.041 DBMET02024 0.054 0.041 DBMET02028 | DBMET02028 | |
| 0.08 | 0.377 | 0.233 | DNA synthesis inhibitor | 0.233 0.08 DBMET02020 0.179 0.155 DBMET02022 | DBMET02020 | |
| 0.024 | 0.328 | 0.113 | Protein kinase C zeta inhibitor | 0.113 0.037 DBMET02020 | DBMET02020 | |
| 0.022 | 0.342 | 0.113 | I kappa B kinase inhibitor | 0.113 0.03 DBMET02020 | DBMET02020 | |
| 0.018 | 0.348 | 0.073 | MAP-kinase-activated kinase 2 inhibitor | 0.073 0.053 DBMET02020 | DBMET02020 | |
| 0.018 | 0.353 | 0.101 | Pim-1 kinase inhibitor | 0.101 0.057 DBMET02020 | DBMET02020 | |
| 0.011 | 0.353 | 0.035 | Erythropoietin receptor agonist | 0.035 0.034 DBMET02021 | DBMET02021 | |
| 0.009 | 0.354 | 0.088 | Phosphodiesterase 4D inhibitor | 0.088 0.043 DBMET02022 | DBMET02022 | |
| 0.079 | 0.435 | 0.195 | Nootropic | 0.195 0.165 DBMET02020 | DBMET02020 | |
| 0.023 | 0.38 | 0.066 | Glutamate dehydrogenase inhibitor | 0.066 0.063 DBMET02025 0.066 0.063 DBMET02026 | DBMET02026 | |
| 0.059 | 0.424 | 0.158 | Focal adhesion kinase 2 inhibitor | 0.158 0.118 DBMET02020 | DBMET02020 | |
| 0.102 | 0.469 | 0.247 | Interleukin 2 agonist | 0.247 0.122 DBMET02021 0.202 0.186 DBMET02025 0.202 0.186 DBMET02026 | DBMET02021 | |
| 0.005 | 0.373 | 0.025 | Protocollagen prolyl hydroxylase inhibitor | 0.025 0.023 DBMET02021 | DBMET02021 | |
| 0.008 | 0.382 | 0.045 | Nicotinic receptor alpha4 subunit antagonist | 0.045 0.044 DBMET02020 | DBMET02020 | |
| 0.091 | 0.483 | 0.132 | Heat shock protein 70 antagonist | 0.132 0.11 DBMET02025 0.132 0.11 DBMET02026 | DBMET02026 | |
| 0.016 | 0.408 | 0.064 | Sirtuin 1 inhibitor | 0.064 0.052 DBMET02028 | DBMET02028 | |
| 0.013 | 0.446 | 0.065 | I kappa B kinase 2 inhibitor | 0.065 0.039 DBMET02020 | DBMET02020 | |
| 0.078 | 0.512 | 0.212 | Apoptosis antagonist | 0.198 0.181 DBMET02021 0.197 0.183 DBMET02025 0.197 0.183 DBMET02026 0.212 0.165 DBMET02028 | DBMET02028 | |
| 0.088 | 0.525 | 0.22 | Peptidyltransferase inhibitor | 0.181 0.127 DBMET02021 0.205 0.093 DBMET02025 0.22 0.076 DBMET02027 0.22 0.076 DBMET02024 0.205 0.093 DBMET02026 0.177 0.133 DBMET02028 | DBMET02024 | |
| 0.044 | 0.49 | 0.097 | Folate antagonist | 0.093 0.08 DBMET02021 0.097 0.071 DBMET02025 0.097 0.071 DBMET02026 | DBMET02026 | |
| 0.009 | 0.469 | 0.089 | Pim-3 kinase inhibitor | 0.089 0.06 DBMET02020 | DBMET02020 | |
| 0.024 | 0.513 | 0.221 | Angiogenesis stimulant | 0.221 0.084 DBMET02021 | DBMET02021 | |
| 0.004 | 0.517 | 0.103 | 5 Hydroxytryptamine 2C agonist | 0.103 0.007 DBMET02020 | DBMET02020 | |
| 0.034 | 0.566 | 0.105 | Hematopoietic | 0.105 0.031 DBMET02021 | DBMET02021 | |
| 0.029 | 0.568 | 0.116 | Histone deacetylase SIRT1 inhibitor | 0.116 0.097 DBMET02021 0.109 0.106 DBMET02028 | DBMET02021 | |
| 0.005 | 0.563 | 0.032 | Melatonin 2 agonist | 0.032 0.024 DBMET02027 0.032 0.024 DBMET02024 | DBMET02024 | |
| 0.018 | 0.634 | 0.218 | Interleukin antagonist | 0.218 0.075 DBMET02021 | DBMET02021 | |
| 0.038 | 0.689 | 0.11 | Factor V inhibitor | 0.11 0.051 DBMET02021 | DBMET02021 | |
| 0.03 | 0.682 | 0.132 | Hepatoprotectant | 0.132 0.13 DBMET02021 | DBMET02021 | |
| 0.015 | 0.671 | 0.083 | DNA directed RNA polymerase inhibitor | 0.083 0.08 DBMET02021 | DBMET02021 | |
| 0.011 | 0.698 | 0.162 | Elastase 1 inhibitor | 0.162 0.005 DBMET02021 | DBMET02021 | |
| 0.035 | 0.778 | 0.353 | Sodium/bile acid cotransporter inhibitor | 0.353 0.038 DBMET02021 0.288 0.091 DBMET02025 0.288 0.091 DBMET02026 | DBMET02021 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |